Mili Interactions
There are 493 drugs known to interact with Mili (ethinyl estradiol/norgestimate), along with 22 disease interactions, and 8 alcohol/food interactions. Of the total drug interactions, 75 are major, 369 are moderate, and 49 are minor.
- View all 493 medications that may interact with Mili
- View Mili alcohol/food interactions (8)
- View Mili disease interactions (22)
Most frequently checked interactions
View interaction reports for Mili (ethinyl estradiol / norgestimate) and the medicines listed below.
- Abilify (aripiprazole)
- albuterol
- bupropion
- buspirone
- cetirizine
- clonazepam
- cyclobenzaprine
- duloxetine
- escitalopram
- famotidine
- Fish Oil (omega-3 polyunsaturated fatty acids)
- fluoxetine
- gabapentin
- hydroxyzine
- ibuprofen
- lamotrigine
- levothyroxine
- magnesium oxide
- melatonin
- metformin
- omeprazole
- propranolol
- sertraline
- spironolactone
- sumatriptan
- tizanidine
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Mili alcohol/food interactions
There are 8 alcohol/food interactions with Mili (ethinyl estradiol / norgestimate).
Mili disease interactions
There are 22 disease interactions with Mili (ethinyl estradiol / norgestimate) which include:
- smoking
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
Report options
QR code containing a link to this page
More about Mili (ethinyl estradiol / norgestimate)
- Mili consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (270)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: contraceptives
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.